M. Alterman, H. O. Andersson, N. Garg, G. Ahlsen, S. Lovgren, B. Classon, U. H. Danielson, I. Kvarnstrom, L. Vrang, T. Unge, B. Samuelsson, and A. Hallberg:
Design and fast synthesis of C-terminal duplicated potent C-2- symmetric P1/P1 '-modified HIV-1 protease inhibitors
Journal of Medicinal Chemistry, 42, 3835-3844 (1999)
K. Olofsson, S. Y. Kim, M. Larhed, D. P. Curran, and A. Hallberg:
High-speed, highly fluorous organic reactions
Journal of Organic Chemistry, 64, 4539-4541 (1999)
J. Hulten, H. O. Andersson, W. Schaal, H. U. Danielson, B. Classon, I. Kvarnstrom, A. Karlen, T. Unge, B. Samuelsson, and A. Hallberg:
Inhibitors of the C-2-symmetric HIV-1 protease: Nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2 ' side chains
Journal of Medicinal Chemistry, 42, 4054-4061 (1999)
U. Bremberg, M. Larhed, C. Moberg, and A. Hallberg:
Rapid microwave-induced palladium-catalyzed asymmetric allylic alkylation
Journal of Organic Chemistry, 64, 1082-1083 (1999)
P. Johannesson, G. Lindeberg, W. M. Tong, A. Gogoll, B. Synnergren, F. Nyberg, A. Karlen, and A. Hallberg:
Angiotensin II analogues encompassing 5,9-and 5,10-fused thiabicycloalkane tripeptide mimetics
Journal of Medicinal Chemistry, 42, 4524-4537 (1999)
T. Linnanen, M. Brisander, L. Unelius, G. Sundholm, U. Hacksell, and A. M. Johansson:
(R)-1,11-methyleneaporphines: Synthesis and interactions with G-protein coupled receptors
Abstracts of Papers of the American Chemical Society, 218, 123-MEDI (1999)
P. Johannesson, G. Lindeberg, W. M. Tong, A. Gogoll, A. Karlen, and A. Hallberg:
Bicyclic tripeptide mimetics with reverse turn inducing properties
Journal of Medicinal Chemistry, 42, 601-608 (1999)
C. Moberg, U. Bremberg, K. Hallman, M. Svensson, P. O. Norrby, A. Hallberg, M. Larhed, and I. Csoregh:
Selectivity and reactivity in asymmetric allylic alkylation
Pure and Applied Chemistry, 71, 1477-1483 (1999)
I. J. P. De Esch, R. C. Vollinga, K. Goubitz, H. Schenk, U. Appelberg, U. Hacksell, S. Lemstra, O. P. Zuiderveld, M. Hoffmann, R. Leurs, W. Menge, and H. Timmerman:
Characterization of the binding site of the histamine H-3 receptor. 1. Various approaches to the synthesis of 2-(1H- imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)cyclopropylamine
Journal of Medicinal Chemistry, 42, 1115-1122 (1999)
W. Berts and K. Luthman:
Synthesis of a complete series of C-4 fluorinated Phe-Gly mimetics
Tetrahedron, 55, 13819-13830 (1999)
S. Borg, R. C. Vollinga, M. Labarre, K. Payza, L. Terenius, and K. Luthman:
Design, synthesis, and evaluation of Phe-Gly mimetics: Heterocyclic building blocks for pseudopeptides
Journal of Medicinal Chemistry, 42, 4331-4342 (1999)
B. B. Hook, C. Brege, T. Linnanen, A. Mikaels, A. Malmberg, and A. M. Johansson:
Derivatives of (R)-2-amino-5-methoxytetralin: Antagonists and inverse agonists at the dopamine D-2A receptor
Bioorganic & Medicinal Chemistry Letters, 9, 2167-2172 (1999)
P. Caldirola, R. Chowdhury, L. Unelius, N. Mohell, U. Hacksell, and A. M. Johansson:
Novel derivatives of 3-(dipropylamino) chroman. Interactions with 5-HT1A and D-2A receptors
Bioorganic & Medicinal Chemistry Letters, 9, 1583-1586 (1999)
S. L. Payne, P. G. Strange, A. M. Johansson, and U. Hacksell:
Investigating mechanisms of agonist action at the human D- 2short dopamine receptor
British Journal of Pharmacology, 126, 109P (1999)